Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients.

Ben-Yosef, R; Or, R; Naparstek, E; Kapelushnik, J; Samuels, S; Slavin, S; Nagler, A

Ben-Yosef, R; Or, R; Naparstek, E; Kapelushnik, J; Samuels, S; Slavin, S; Nagler, A.

Affiliation

Ben-Yosef R; Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.

Am J Clin Oncol ; 20(4): 419-23, 1997 Aug.

Article in En | MEDLINE | ID: mdl-9256903

Subject(s)

Bone Marrow Purging; Breast Neoplasms/therapy; Glycine max; Hematopoietic Stem Cell Transplantation; Lectins/therapeutic use; Soybean Proteins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/pathology; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Lectins/adverse effects; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local/pathology; Neoplasm Staging; Plant Lectins; Remission Induction; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Glycine max / Breast Neoplasms / Bone Marrow Purging / Hematopoietic Stem Cell Transplantation / Soybean Proteins / Lectins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Am J Clin Oncol Year: 1997 Type: Article Affiliation country: Israel

Search on Google

Add to My VHL

XML

PubMed Links